Cargando…
Mizoribine treatment in an elderly diabetic patient with antisynthetase-associated interstitial lung disease
Objective: Immunosuppressive therapy for interstitial lung disease (ILD) is often necessary, but the standard regimen for antisynthetase-associated ILD has not been established. Patient: An 80-year-old man was hospitalized for severely progressive dyspnea. Bilateral interstitial shadows occurred 1 m...
Autores principales: | Nagai, Kei, Niisaka, Masahiro, Nakajima, Masayuki, Sakata, Yoshinori, Nakamura, Yoshiharu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Association of Rural Medicine
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530592/ https://www.ncbi.nlm.nih.gov/pubmed/33033547 http://dx.doi.org/10.2185/jrm.2020-018 |
Ejemplares similares
-
Antisynthetase Syndrome with Severe Interstitial Lung Disease in Pregnancy
por: Dumitrascu, Catalina I., et al.
Publicado: (2021) -
Antisynthetase syndrome and interstitial lung disease: A case report
por: Dahal, Krishna, et al.
Publicado: (2022) -
Fanconi syndrome in an elderly patient with membranous nephropathy during treatment with the immunosuppressant mizoribine
por: Nishikawa, Sho, et al.
Publicado: (2022) -
Antisynthetase syndrome presenting as interstitial lung disease: a case report
por: Badshah, Aliena, et al.
Publicado: (2019) -
Recovery from severe metabolic alkalosis with acute kidney injury due to
gastric cancer: a case report
por: Hirai, Kenta, et al.
Publicado: (2021)